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Edited by Varda RotterAbstract Accumulative evidence demonstrates that normal as
well as cancer stem cells can be identiﬁed as a side population
following Hoechst 33342 staining and ﬂow cytometric analysis.
This popular method is based on the ability of stem cells to eﬄux
this ﬂuorescent vital dye. We demonstrate that Hoechst 33342
can aﬀect cell diﬀerentiation, suggesting potential complications
in the interpretation of data.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Stem cell1. Introduction
In the past few years, Hoechst 33342 staining has been
widely used for identifying normal as well as cancer stem cells.
This technique is based on the observation that following
staining with Hoechst 33342, a small subset of cells actively ef-
ﬂuxes this ﬂuorescent vital dye. Hence, when analyzed simulta-
neously on a ﬂow cytometer at two emission wavelengths (red
and blue), some low ﬂuorescent cells may appear as a ‘‘side
population’’ (SP) well separated from the main population of
high ﬂuorescent cells (MP). The ﬁnding that in murine bone
marrow SP cells are enriched in haematopoietic stem cells
(HSC) [1] leads to use Hoechst 33342 staining for the puriﬁca-
tion of stem cells from other tissues. Thus, for example, the SP
phenotype has been used to identify stem cells from muscle [2],
liver [3], brain [4], testis [5], epidermis [6], dental pulp tissue [7]
and bone [8]. Likewise, SP analysis has been used to identify
cancer stem cell populations [9–11]. Therefore, even if some
conﬂicting results have been reported [12–14], Hoechst exclu-
sion is commonly viewed as a stem cell feature [15]. However,
a major question regarding the association of SP phenotype to
stem cells is the existence of a functional relationship between
Hoechst exclusion and stemness. Indeed, even if the molecular
determinant of the SP phenotype is identiﬁed as the ABC
transporter Bcrp1/ABCG2 [16], its physiological role in the
maintenance of the stem cell phenotype remains elusive. Thus,
Bcrp1/ mice are fertile and do not show any physiological or
anatomical abnormalities [17]. Moreover, the reduced number*Corresponding authors. Fax: +33 4 76 76 56 19.
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duced number of haematopoietic stem cells or with any stem
cell-associated disease [17]. Therefore, we cannot formally ex-
clude that the association of SP phenotype with haematopoi-
etic stem cell, even if valuable, is coincidental.
Although the use of Hoechst 33342 for stem cell analysis is
relatively recent, it has long been known that Hoechst 33342
is a non-intercaling AT base pair-speciﬁc ligand which binds
to cellular DNA by non-covalent association [18]. Conse-
quently, this speciﬁc vital stain for DNA has been used since
many years in conjunction with ﬂuorescence activated cell sort-
ing in cell cycle analysis [19,20]. Thus, it is during a cell cycle
analysis with Hoechst 33342 that the serendipitous discovery
of SP cells was done [1].
A prerequisite for a general use of Hoechst 33342 in stem cell
sorting is that this ﬂuorescent dye does not interfere with cell
diﬀerentiation. In this regard, it is noteworthy that even if
Hoechst 33342 is usually considered as non-toxic, it has been
demonstrated, more than one decade ago, that it induces
teratocarcinoma cell diﬀerentiation [21]. However, this report
published well before the use of Hoechst 33342 for stem cell
sorting retained little attention (two citations according to
the Scopus Citation Tracker). Here, we demonstrate using
two cell lines distinct from teratocarcinoma cells that Hoechst
treatment, as it is performed during staining for SP analysis,
can aﬀect cell diﬀerentiation.2. Materials and methods
2.1. Cell culture
The C2C12 cell line (ATCC product number CRL-1772) was estab-
lished from adult C3H mouse leg muscle. It has been widely used for
studying myogenesis since its diﬀerentiation produces myotubes. The
PC12 cell line (ATCC number CRL-1721) was derived from a trans-
plantable rat pheochromocytoma [22]. Because NGF-PC12 treated
cells extend neurites this cell line has been considered as a model sys-
tem for neuronal diﬀerentiation studies. PC12 cells were cultured at
37 C in growth medium (RPMI with 5% fetal bovine serum and
10% horse serum). C2C12 cells were passaged in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) supplemented with 10% foetal bovine serum
(FBS). For experiments C2C12 cells were plated at 2.5 · 103 cells/cm2
(low density) or 2 · 105 cells/cm2 (high density). PC12 cells were plated
at 5 · 103 cells/cm2. For quantiﬁcation of cell proliferation, control
cells and Hoechst-treated cells were detached by trypsinization, and
the number of viable cells was determined using trypan blue exclusion
and a hemocytometer.2.2. Hoechst labelling and FACS analysis
Hoechst concentrations used for SP sorting in published data vary
from 2.5 lg/ml to 12.5 lg/ml, 5 lg/ml being the concentration most of-blished by Elsevier B.V. All rights reserved.
Fig. 1. FACS analysis of C2C12 and PC12 cells. C2C12 (A, C) or PC12 (B, D) cells were incubated with Hoechst 33342. Controls (C, D) were also
incubated with verapamil to block the transporter responsible for the Hoechst exclusion. SP cells are indicated.
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studies.
For Hoechst staining and side population analysis, cells were re-
trieved from subconﬂuent culture by trypsinization, resuspended at
106 cells/ml in prewarmed DMEM containing 2% FBS, 10 mM Hepes,
then incubated for 90 min at 37 C with Hoechst 33342 (5 lg/ml ﬁnal
concentration, Sigma) with intermittent mixing. Control cells were gi-
ven Verapamil (50 lM ﬁnal concentration, Sigma) to block pumps that
exclude the Hoechst. At the end of incubation, cells were spun down in
the cold and washed twice in cold HBSS (purchased from Gibco-Invit-
rogen) containing 2% FBS and 10 mM Hepes. Then cells were either
seeded on culture dishes or FACS analyzed.
Cytometric analyses were performed on a FACS Vantage SE option
DiVa and 1.106 cells were analyzed for each sample. Dead cells were
excluded from the plots based on propidium iodide staining (5 lg/
ml). Hoechst staining intensity was evaluated by measuring the ﬂuores-
cence mean intensity of the entire cell population. Data were reana-
lyzed with FCS Express 2 software (De Novo Software, Thornhill,
Canada).
2.3. Diﬀerentiation index
To quantify the fusion of C2C12 cells, cells were ﬁxed with metha-
nol, processed for immunoﬂuorescence using an anti-myosin heavy
chain (MHC) monoclonal antibody and stained with propidium io-
dide. The diﬀerentiation index was calculated as the percentage of nu-
clei in multinucleated MHC-positive cells relative to the total number
of nuclei.Fig. 2. Growth characteristics of C2C12 and PC12 Hoechst-treated
cells versus control cells.3. Results and discussion
In a ﬁrst set of experiments exponentially growing C2C12
cells were treated for 90 min with 5 lg/ml Hoechst 33342, asdescribed in Section 2. Control cells were treated similarly
without Hoechst addition. After washing, cells were then either
FACS analyzed or replated at a cell density of 2.5 · 103 cells/
cm2. Using these experimental conditions, and as previously
described [23], SP cells were detected in C2C12 cells
(Fig. 1A). Moreover, Hoechst treatment did not decrease cell
viability (data not shown) or proliferation (Fig. 2). Likewise
the treatment had no apparent eﬀect on cell myogenic diﬀeren-
tiation, since both control and Hoechst-treated cell culture dis-
played extensive myotubes formation eight days after plating
(Fig. 3A and B). According to this, ﬂuorescence was no longer
observable in the nuclei of treated cells (Fig. 4A and B).
Fig. 3. Eﬀects of Hoechst 33342 on C2C12 and PC12 cell diﬀerentiation. C2C12 were plated at low cell density (A, B) or high cell density (C, D) as
described in Section 2. (A and C) are control cells; (B and D) are Hoechst 33342 treated cells. PC12 cells (E and F) are incubated with a sub-optimal
concentration of NGF (10 ng/ml). (E) control cells, (F) Hoechst-treated cells.
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(2 · 105 cells/cm2) cell fusion was dramatically reduced in Hoe-
chst-treated cells only (Fig. 3C and D). Moreover, Hoechst
staining was readily observable eight days after treatment
(Fig. 4D and G). These diﬀerences between low and high den-
sity cell cultures can be attributable to a dilution eﬀect of Hoe-
chst due to cell ampliﬁcation, since low density C2C12 cells
proliferated very actively with a doubling time of about 19 h
[24]. Comparison of the diﬀerentiation index (% of total nuclei
contained within myosine heavy chain-expressing myotubes)
between control C2C12 cells and Hoechst treated cells con-
ﬁrmed that Hoechst 33342 staining inhibited C2C12 cell diﬀer-
entiation (Fig. 4H). This eﬀect is even more dramatic when
C2C12 cells were cultured in serum-free medium, a culture
condition known to increase C2C12 cell fusion (Fig. 4H). Ta-
ken together these results demonstrate that Hoechst interferes
with C2C12 cell fusion as long as the dye is present in the nu-
cleus. Additional evidence for Hoechst eﬀect on cell diﬀerenti-
ation was provided using PC12 cells. These cells have a
doubling time of about 92 h and diﬀerentiate in neurite bearing
cells when NGF is added to cell culture at a concentration of
50 ng/ml [22]. Flow cytometry analysis with Hoechst 33342
staining demonstrated PC12 cells included a small SP cells
compared to C2C12 cells, and is therefore a suitable experi-mental model to study the eﬀects of Hoechst retention
(Fig. 1B). Hoechst treatment had no eﬀect on neurite out-
growth (data not shown), nor decreased cell proliferation
(Fig. 2). However, Hoechst staining synergizes with sub-opti-
mal concentration of NGF (10 ng/ml) in inducing neurite out-
growth (Fig. 3E and F). As expected from the eﬀects on cell
diﬀerentiation, Hoechst staining is still evident after 5 days
(Fig. 4F and G). The low percentage of SP cells observed both
in C2C12 and PC12 cell lines (Fig. 1) excludes that the ob-
served eﬀect is ascribable to SP cells only. Taken together these
data suggest that Hoechst staining can aﬀect cell diﬀerentiation
as long as the dye is present in the nucleus. In this regard our
data are consistent with a previous report on the eﬀect of Hoe-
chst 33342 on the diﬀerentiation of embryonic carcinoma cell
lines [21]. In fact, these results are not astonishing if we con-
sider that Hoechst 33342 interaction with DNA alters TATA
Box Binding Protein (TBP)/DNA complexes [25], and that this
dye is a speciﬁc topoisomerase-I poison [26]. Interestingly,
alterations in topoisomerase I activity induces embryonal car-
cinoma, neuroblastoma and leukaemia cell diﬀerentiation [27–
29]. Likewise, evidence has been presented suggesting that
topoisomerase I activity is required for C2C12 myogenic diﬀer-
entiation [24]. However, it should be noted that our results are
obtained on C2C12 and PC12 cells. Therefore, possible eﬀects
Fig. 4. Hoechst staining of Hoechst-treated cells and C2C12 diﬀerentiation index. C2C12 (A, B, C, D) and PC12 (E, F) cells were treated with
Hoechst (B, D, F) and ﬁxed 8 days (C2C12) or 4 days (PC12) after treatment. C2C12 were plated at low density (A, B), or high density (C, D). Blue
nuclear ﬂuorescence is only observed in Hoechst-treated C2C12 plated at high density (D), and in Hoechst-treated PC12 cells. Nuclei are
counterstained with propidium iodide (red). G: Decrease in Hoechst staining detected by FACS analysis. (AU): arbitrary ﬂuorescence unit. H:
Diﬀerentiation index of C2C12 cells. The values reported in the graph are the means ± standard deviations (S.D.) from three separate experiments.
D. Adamski et al. / FEBS Letters 581 (2007) 3076–3080 3079of Hoechst staining on cell diﬀerentiation should be systemat-
ically studied for other cell lines or primary cell culture. In this
regard it is noteworthy that Hoechst sensitivity varies among
cell types [30,31]. The ﬁnding that Hoechst 33342 can aﬀect dif-
ferentiation suggests potential complications in the interpreta-
tion of data obtained in SP analysis. Hence, Hoechst 33342
eﬀects on cell diﬀerentiation will be more critical on MP cells
which retain the dye than on SP cells which exclude it. This
raises the embarrassing possibility that in some experiments,
the diﬀerences observed on cell diﬀerentiation between SP
and MP cells could be a consequence of the higher exposure
of MP cell DNA to this vital ﬂuorescent dye.
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